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Abstract. Two COOH terminally truncated variants of
ribophorin I (RI), a type I transmembrane glycoprotein
of 583 amino acids that is segregated to the rough
portions of the ER and is associated with the protein-
translocating apparatus of this organelle, were expressed
in permanent HeLa cell transformants. Both variants,
one membrane anchored but lacking part of the cyto-
plasmic domain (RI,67) and the other consisting of the
luminal 332 N112-terminal amino acids (RI332), were
retained intracellularly but, in contrast to the endoge-
nous long lived, full length ribophorin I (tv2 = 25 h),
were rapidly degraded (ti/2 < 50 min) by a nonlyso-
somal mechanism. The absence of a measurable lag
phase in the degradation of both truncated ribophorins
indicates that their turnover begins in the ER itself.
The degradation of R1467 was monophasic (t2 = 50
min) but the rate of degradation of R1332 molecules in-
creased about threefold -50 min after their synthesis.
Seveal pieces of evidence suggest that the increase in
degradative rate is the consequence of the transport of
81332 molecules that are not degraded during the first
phase to a second degradative compartment. Thus,
IKE any subcellular organelle, the ER contains proteins
that permanently reside within it and function in its
various biosynthetic and metabolic activities. How
ever, it also contains proteins with other subcellular destina-
tions that transit through the ER after they are inserted into
its membrane or translocated into its lumen during the course
oftheir synthesis on membrane-bound ribosomes (for review
see Sabatini and Àdesnik, 1989). Polypeptides synthesized
in the ER not only undergo various co- and posttranslational
modifications within the organelle, but are also folded and
in some cases oligomerized to form multisubunit proteins
within the ER itself (for review see Rose and Doms, 1988;
Hurtley and Helenius, 1989), apparently assisted by resident
proteins which prevent the egress ofincompletely assembled
products (Boleet al., 1986; deSilva et al., 1990; Siegel and
Walter, 1989).
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when added immediately after labeling, ionophores
that inhibit vesicular flow out of the ER, such as car-
bonyl cyanide m-chlorophenylhydrazone (CCCP) and
monensin, suppressed the second phase of degradation
of 81332 . On the other hand, when CCCP was added
after the second phase of degradation of 81332 was ini-
tiated, the degradation was unaffected. Moreover, in
cells treated with brefeldin A the degradation of 81332
became monophasic, and took place with a half-life
intermediate between those of the two normal phases.
These results point to the existence of two subcellular
compartments where abnormal ER proteins can be de-
graded. One is the ER itself and the second is a non-
lysosomal pre-Golgi compartment to which ER pro-
teins are transported by vesicular flow. A survey of the
effects of a variety of other ionophores and protease
inhibitors on the turnover of 81332 revealed that metallo-
proteases are involved in both phases of the turnover
and that the maintenance of a high Ca2+ concentration
is necessary for the degradation of the luminally trun-
cated ribophorin.
In recent years it has become apparent that many proteins
that are normally transported from the ER to the Golgi ap-
paratus, when improperly folded or incompletely assem-
bled, undergo degradation within the ER by a proteolytic
system that has not yet been fully characterized (for review
see Klausner and Sitia, 1990) . Many abnormal or unassem-
bled polypeptide subunits are degraded very rapidly, with
half-lives of 4-60 min (Lippincott-Schwartz et al ., 1988;
Stoller and Shields, 1989), whereas others, although appar-
ently not leaving the ER, are much more stable (Bonifacino
et al., 1989; Wileman et al., 1990a). For example, the a, ß
and 6-chains of the T cell receptor (TCR),' type I trans-
membrane polypeptides that remain in the ER when ex-
1. Abbreviations used in this paper: BFA, brefeldin A; BiP, heavy chain
binding protein; CCCP, carbonyl cyanide m-chlorophenylhydrazone; endo
H, endoglycosidase H; RI332 and R1467, truncated forms of ribophorin I
containing its 332and467 NH2-terminal amino acids, respectively; TCR,
T cell receptor.
57pressed in transfected cells in the absence of other subunits
necessary for multimerization, undergo a rapid degradation,
whereas the y and e subunits are stable, although they too
are apparently retained in the ER (Lippincott-Schwartz et
al., 1988; Chen et al., 1988; Bonifacino et al., 1989; Wile-
man et al., 1990x). In addition, a truncated variant of the a
chain of the TCR that contains only the luminal domain,
which is also retained in the ER, is much more stable than
the intact polypeptide. In fact, it has been shown that in the
case of the TCR a chain the rapid degradation of the native
polypeptide depends on the presence of its specific trans-
membrane domain (Bonifacino et al., 1990). Transmem-
brane portions of 3-hydroxy-3-methylglutaryl coenzyme A
reductase, a permanent resident protein of the ER that
traverses the membrane several times, have also been shown
to play a critical role in determining the enhanced degrada-
tion rate of that protein under certain metabolic conditions
(Jingami et al ., 1987) .
It is not clear to what extent the natural turnover of normal
resident proteins of the ER involves the same degradative
system that destroys defective and incompletely assembled
polypeptide subunits of proteins that are normally exported
from the ER. The turnover of some ER proteins, such as
cytochrome P450 and its reductase, which accumulate at
high levels after administration of some drugs and are
degraded after removal ofthe inducer, has been shown to in-
volve autophagy (Masaki et al., 1987), a process which re-
quires lysosomal functions and in hepatocytes appears to be
the major mechanism for overall cellular protein degradation
(Gordon and Seglen, 1982) . The ER degradation of abnor-
mal and incompletely assembled polypeptides, however, oc-
curs by a different pathway, since it is not affected by drugs
that blocklysosomal proteolysis (Lippincott-Schwartz et al.,
1988; Stoller and Shields, 1989).
In this paper we studied the fate of two abnormal, COOH
terminally truncated variants of ribophorin I (RI), a resident
membrane glycoprotein of the ER that is segregated to the
rough portions of this organelle (Kreibich et al., 1978a,b).
This type I transmembrane protein is highly stable (t2 =
25 h) (Rosenfeld et al ., 1984) and is part ofa supramolecular
complex that includes other integral ER membrane proteins
that are components of the polypeptide translocation appara-
tus and the ribosome binding sites present in the rough ER
(Kreibich et al., 1978a,b; Marcantonio et al., 1984; Amar-
Costesec et al., 1984; Yu et al ., 1990). One of the truncated
variants of ribophorin I we examined contained only a large
portion of the luminal domain of the protein, whilethe other
also included the transmembrane domain. Both of these
polypeptides were found to be highly unstable and began to
be degraded in the ER soon after their synthesis. Whereas
the degradation of the membrane-anchored variant showed
monophasic kinetics andappeared to be completed in the ER
itself, the luminally truncated molecules were degraded with
biphasic kinetics and we provide evidence that this reflects
the transfer of a substantial fraction of them to a second pre-
Golgi compartment, where an even more rapid degradation
took place. Pharmacological studies indicated that degrada-
tion in both pre-Golgi compartments involves the participa-
tion of metalloproteases and that maintenance of a high
Cal+ concentration in the lumen of these compartments is
essential for rapid degradation of the luminally truncated
molecule.
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Materials andMethods
Reagents
The pSP65 plasmid vector waspurchasedfromPromega Biotech (Madison,
WI). Polymerases, restriction endonucleases, and mungbean nuclease were
from New England Biolabs (Beverly, MA) and Bethesda Research Labora-
tories (Gaithersberg, MD), nucleotides and endoglycosidase H (endo H)
from Boehringer-Mannheim Biochemicals (Indianapolis, IN), and [35S]-
methionine (1,100 Ci/mmol) from new England Nuclear (Boston, MA).
HBSS and MEM were from Whittaker Bioproducts Inc. (Walkersville,
MD), methionine-free RPMI 1,640 from Mediatech (Washington, DC),
and FBS from Hazleton Biologics, Inc. (Lenexa, KS). Cell culture-tested
Geneticin (G 418), sodium butyrate, protein A-Sepharose CL-4B beads,
protease inhibitors, and ionophores were obtained from Sigma Chemical
Co. (St. Louis, MO), Trasylol (Aprotinin) from Mobery Chemical Corp.
(New York), and En3Hance from New England Nuclear Research Products
(Boston, MA). When not specified, reagents were purchased from Fisher
Scientific Co. (Pittsburgh, PA). Brefeldin A (BFA) was obtained as a gift
from Dr. Richard Klausner (National Institute ofChild Health and Human
Development, Bethesda, MD). The anti-Bip antibody was kindly provided
by Dr. D. Bole (HowardHughes Medical Institute, University of Michigan,
Ann Arbor, MI). The rabbit polyclonal antibodies against rat liver ribopho-
rin I have been previously described (Marcantonio et al., 1984; Yu et
al ., 1990).
Plasmid Construction and Transfection ofHeLa Cells
with TlruncatedRatRibophorin IGenes
The rat ribophorin IcDNA (Hamik-Ort et al., 1987) was removed fromthe
plasmid vector pGEM-1 by digestion with EcoRl and HindIII, enzymes
which cleave at the 5' end ofthecDNA and within the 3'untranslated region
(residue 1964), respectively (Fig. 1 B), and subcloned into the plasmid vec-
tor pSP65. To produce theYtruncations in the cDNA, a chemically synthe-
sized double-stranded oligonucleotide (Fig. 1 A) containing three termina-
tion codons and four restriction enzyme cleavage sites (NcoI at the Send,
HindIII at the 3' end, and Mlul and C1al in between) was cloned between
unique NcoI and HindIII sites within the 3'-noncoding region of the
ribophorin I cDNA (Fig. 1 B) in the plasmid pSP65. When the ribophorin
I cDNA was cut in its coding region with one of the restriction enzymes
indicated on the map, it was possible to choose a cleavage site within the
oligonucleotide so that cleavage at both sites, followed by mung
bean-nucleasetreatment and circularization, placed a terminationcodon in
frame immediately after the ligation site.
By using this strategy it is possible to generate cDNAs coding for car-
boxy terminally truncated forms of ribophorin I that contain, in addition
tothesignalpeptide (residues -1 to -22), variousN112-terminalportions of
the mature ribophorin I sequence. These constructs were cloned into the
expressionvector pSV2 tk neo, and permanenttransformants ofHeLa cells
were obtained after selection for growth in the presence of0.4% geneticin
(Compton et al., 1989). In the work reported here, cloned HeLa cell trans-
formants expressing the truncated ribophorin I polypeptides, RI332 or RI467,
were used. R1332 lacks the membrane-anchoring domain (residues 416-433)
but contains a large portion of the luminal domain, including the N-glyco-
sylation site at Asn275 used in mature ribophorin I, whereas RI467 only
lacks the last 116 residues ofthe cytoplasmic domain (see Fig. 1, D and E).
The two permanent transformant cell lines are referred to as HeLa-R1332
and HeLa-R467, respectively. To achieve higher levels of expression the
cells were treated with 5 mM sodiumbutyrate (Kruh, 1982; Rizzolo et al.,
1985) for 12 h and cultured for at least 1 wkbefore they were used for label-
ing experiments. This treatment was repeated when the level ofexpression
of the transfected gene decreased significantly.
CellLabeling, Immunoprecipitation, and
GelElectrophoresis
The transfected HeLa cells were plated in 35-mm dishesto a density of5-8
x 105 cells per dish. After 24 h ofincubation, they were rinsed twice with
HBSS free of methionine, and incubated for 30 min in methionine-free
RPMI 1640 to depletethe intracellularmethioninepool. In pulse-chase ex-
periments, cells were then labeled with [35S]methionine in methionine-free
RPMI 1640 (125,uCi/ml) for 5 min (unless noted otherwise) andthen trans-
ferred to MEM containing 7% FBS and5 mMunlabeled methionine. Chase
periods were terminated by placing the dishes on ice.
Cells were washed with ice-cold PBS (150 mM NaCl, 50 mM Na-
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phosphate, pH 7.4) and lysatespreparedin SDS-containing buffer (1 mg/ml
immunoglobulin-free BSA, 95 mM NaCl, 3 mM EDTA, 2% SDS, 25 mM
Tris-HCI, pH 7.4, 1 mM DTT, 0.5 ug/mI leupeptin, 1 mg/ml leu-leu4eu,
and 20 U/ml traysol) by scraping off the cells in lysis buffer with the aid
ofa rubber policeman. Lysates were transferred to Eppendorf tubes, soni-
cated twice for 15 susing amicrotip (HeatSystems-Ultrasonics, Inc., Plain-
view, NY), boiled for 2 min and finally diluted fourfold with a dilution
buffer that had the same composition as lysis buffer, but contained 0.2%
SDS and 1.25% Triton X-100. All subsequentsteps were carried out at4°C.
The diluted cell extracts were centrifuged for 15 min at 15,000 g in a cen-
trifuge (model 5412; Eppendorf Inc., Fremont, CA) to remove unsolubi-
lized material and were then incubated with protein A-Sepharose CL-4B
beads for 30 min and recentrifuged for 2 min in the Eppendorf centrifuge
to remove material thatbinds nonspecifically to thebeads. The supernatants
were incubated overnight with the polyclonal anti-ribophorin I serum in a
1:500 dilution in the presence of protein A-Sepharose CL-4B beads. The
beads were washed three times withdilution buffer and twice with PBS. Im-
munoprecipitates were dissolved in samplebuffer (20% glycerol, 5 % SDS;
10 mM Tris-HCI, pH 7.4), boiled for 5 min, and analyzed by SDS-PAGE
(10% gels) (Laemmli, 1970). Thegels were prepared for fluorography with
ENIHANCE, dried and exposed at -70°C using film (X-Omat AR; East-
man Kodak and Co., Rochester, NY). Whennecessary, immunoprecipitates
were treated with endo H, as described (Rosenfeld et al., 1984).
To quantitate levels of labeledproteins, fluorograms were scanned using
an optical scanning densitometer (model GS300; Hoefer Scientific Instru-
ments, San Francisco, CA). The intensities ofthe bands corresponding to
the truncated ribophorins were normalized with respect to the intensity of
the endogenous intact ribophorin I band in the same lane. When pulse
periods ofonly 5 minwere used, the highestintensityoflabeling ofthetrun-
catedribophorinrelative to that ofthe endogenous HeLa cellintact ribopho-
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Schematic representation
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rin I occurred at 10minofchase. Therefore, the relative intensities atdiffer-
ent chase times were expressed as percentages of the 10-min value. First
order rates of degradation were obtained by linear regression analysis of
semi-log plots using the Minitabl program (release 7.2; Minitab Project,
University Park, PA). Since the decay curve for RI332 suggested a biphasic
degradation, "coefficients ofdetermination" were calculated for all possible
second phases todetermine theoptimal breakpointbetween thetwophases.
Sequential Immunoprecipitation withAnti-BiPand
Anti-Ribophorin IAntibodies
HeLa-R1332 cells (5 x 105 cells per 60-mmtissue culture dish) weregrown
in MEM, containing 5% dialyzed FBS, 4001Ag neomycin/ml, and 25 jXi
[35S]methionine/ml, for 48 h with one medium replacement halfway
through the incubation. After a chase incubation for 3.5 h, the cells were
starved for methionine (30 min in serum-free MEM without methionine)
and labeled again, this time for 10 min, with 125 liCi [35S]methionine/ml
in serum-free MEM. The cells were then lysed in a nondenaturing buffer
containing 1% NP-40,0.05% SDS, 150 mM NaCl, 50 mM Tris-HCI, pH
7.5, 10 mM n--glucose, 5 U/ml hexokinase (type VI, from bakers yeast, ob-
tained from Sigma Chemical Co.), and protease inhibitors (see also Dorner
et al., 1987). Two equal aliquots of the lysate (12% ofthe total volume)
were used for immunoprecipitation witha mouse monoclonal anti-BiPanti-
body (4.8 pl). Immunocomplexesrecovered usingproteinA-Sepharose CL-
4B beads were washed successively with lysisbuffers containing 1% NP-40,
0.5% NP-40, and then 0.1% NP-40 without SDS, before a final wash with
PBS. The immunoprecipitate obtained from one aliquot was analyzed
directlyby SDS-PAGE, whereasthe other waseluted fromthebeads by boil-
ing for 3 minin2% SDS lysis buffer and subjected toa second immunopre-
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NaFigure 2. A truncated form of ribophorin I (RI332) synthesized in
HeLa cell transformants is not secreted . HeLa-R1332 cells were la-
beled with [35S]methionine for 90 min and chased for 0 (lanes a,
b, and c), 40 (lanes d, e, andf ), or 90 (lanes g, h, and i) min . The
media (M) were recovered and the cells (C) were lysed in an SDS-
containing buffer. The cell lysates were divided into two equal ali-
quots and media (M ; lanes c, f, and i) and cell lysates (C ; lanes
a, b, d, e, g, and h) were immunoprecipitated with a polyclonal
anti-ribophorin I antibody. The inununoprecipitates obtained from
one aliquot ofeachcell lysatewere subsequently digested with endo
H (lanes b, e, and h) . All samples were analyzed onSDS polyacryl-
amide (10%) gels and fluorographs (12 h) were obtained .
cipitation using anti-ribophorin I antibodies . To dothis, the beads were re-
moved by sedimentation and 3 vol of dilution buffer containing 0 .2% SDS
and 1.25% Triton X-100 (see above) were added to the supernatant before
addition of anti-ribophorin I antibody and fresh protein A-Sepharose
beads. In parallel to this, a third equal aliquot of the lysate was used for
immunoprecipitation under the usual denaturing conditions with anti-ribo-
phorin I antibodies, so that the amount of R1332 recovered after sequential
immunoprecipitation with anti-BiP and anti-R1332 antibodies could be
compared with the total amount of RI332 in the sample .
Results
Rapid 7brnover of TruncatedRibophorins: Biphasic
DegradationoftheAnchorless Variant
Intact rat ribophorin I (583 amino acids) consists of a lumi-
nal domain of 415 residues that has a single N-linked, high-
mannose oligosaccharide chain at Asn2 ,5 , a transmembrane
segment extending from residues 416 to 433, and a cytoplas-
mic domain 150 amino acids in length (Harnik-Ort et al .,
1987) . We first examined the fate of a truncated form of
ribophorin I (RI332) that lacks the cytoplasmic and trans-
membrane domains, as well as 84 amino acids ofthe luminal
domain, in permanent transformants ofHeLa cells express-
ing this protein . Immediately after labeling with [35S]methi-
onine for 90 min (Fig . 2, lanes a-c), or after chase periods
of 40 and 90 min (Fig. 2, lanes d-fand g-i ), an intensely
labeled polypeptide of the size expected for the truncated
ribophorin (M, = 38 kD) was detected by immunoprecipi-
tation in cell lysates (Fig . 2, lanes a, d, and g) but at no time
was it found in the culture medium (Fig. 2, lanes c, f, and
i) . Like the endogenous intact glycoprotein (Rosenfeld et
al ., 1984), the truncated ribophorin I remained endo H sen-
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sitive throughout the labeling and chase periods (Fig . 2,
lanes b, e, and h) . This could be taken as evidence that this
polypeptide does notreach the medial region ofthe Golgi ap-
paratus . In separate work, 2 we have demonstrated that this
is, in fact, the case . The failure of ribophorin I and its trun-
cated derivative to become endo H resistant appears, how-
ever, to reflect incapacity of these polypeptides to serve as
substrates for the Golgi enzymes that modify core oligosac-
charide chains. 2
The time-dependent changes in the intensities of the
ribophorin I and 81332 bands in Fig . 2 suggest that the intact
and anchorless ribophorin I molecules synthesized in the
same transformants have markedly different stabilities . This
is strikingly demonstrated in Fig . 3 A in which the relative
amounts of labeled R1332 and endogenous ribophorin I can
be compared after different chase periods extending up to
24 h . Although much more heavily labeled than the endoge-
nous protein at the end of the pulse period, the truncated
ribophorin was no longer detectable after 8 h of chase, while
at this time the intensity of the band corresponding to ribo-
phorin I had undergone little change.
To determine whether the rapid turnover of R1332 was
solely a consequence of its lacking themembrane anchor, the
kinetics of degradation of RI46,, a polypeptide that in addi-
tion to the entire luminal domain ofribophorin I contains the
transmembrane segment and only 34 amino acids of the cy-
toplasmic domain, was examined . It was found that RI46,,
which is also synthesized in large amounts in the correspond-
Figure 3. Twotruncated forms ofribophorin I, one thatis still mem-
brane anchored and another that contains only part of the luminal
domain, are rapidly degraded . HeLa-R1332 (A) and HeLa-RI46,
cells (B) were preincubated in a methionine-free medium for 30
min, labeled with [35S]methionine for 30 min, and chased for up
to 28 h . Immunoprecipitates obtained from cell lysates were ana-
lyzed by SDS-PAGE followed by fluorography .
2 . Ivessa, N. E., C . DeLemos-Chiarandini, Y . S . Tsao, A . Tàkasuki, M.
Adesnik, D. D. Sabatini, andG. Kreibich, manuscript submitted for publi-
cation .
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Figure 4. The two truncated forms of ribophorin I are rapidly de-
graded but with a different kinetics. HeLa-R1332 (0) or HeLa-R467
cells (A), respectively, were preincubated in a methionine-free me-
dium for 30 min and pulse labeled with [35S]methionine for 5 min.
Immunoprecipitates of cell lysates obtained after chase periods of
up to 150 min were analyzed by SDS-PAGE and the resulting
fluorograms were quantitatively evaluated as described in Materials
and Methods. In the inset, a semi-log plot of the same data shows
the first order degradation kinetics for the two proteins.
ing HeLa cell transformants, also undergoes rapid degrada-
tion, albeit at a significantly slower rate than the anchorless
ribophorin (Fig. 3 B) . A quantitative kinetic analysis of the
degradation of the two truncated ribophorins carried out in
cell transformants that were labeled for 5 min and chased for
closely spaced intervals extending up to 150 min (Fig. 4),
showed that whereas the decay of RI,6, follows simple first
order kinetics with a half-life of -50 min, the degradation
of the anchorless protein is biphasic.
The biphasic character of the degradation of R1332 was
clearly demonstrated by an analysis of decay data from six
independent experiments (Fig. 5) which gave half-lives of 59
f 12 and 18 f 6 min for the first and second degradative
phases, respectively, with the first phase lasting for 49 f 6
min. A two-sample t test showed that the values of the two
half-lives of R1332 are significantly different at a level of P =
0.001. It is perhaps fortuitous that the half-life of the first
phase of degradation of R1332 is similar to that of R1467 (t2 =
47 min).
Since both truncated proteins began to be degraded im-
mediately after their synthesis, it can be presumed that the
degradation process begins in the ER itself. The monophasic
character of the turnover of RL67 indeed suggests that the
degradation of this polypeptide is completed in the ER. On
the other hand, the existence of a second accelerated phase
of degradation for 81332 is compatible with the notion
(tested experimentally below) that molecules ofthis type that
have not been degraded in the ER after 50 min are transferred
to a second compartment where they are degraded more
rapidly.
We considered, however, the alternative possibility that
the two phases of degradation of 81332 reflect a transition in
Tsao et al. Pre-Golgi Degradation of Truncated Ribophorins I
the folding or assembly state of the protein. It is known
(Hurtley and Helenius, 1989) that many improperly folded
proteins synthesized in the ER become associated with BiP,
a resident ER protein that may also assist in the assembly of
some multisubunit proteins. It was therefore conceivable that
the initial slow phase of R1332 degradation reflects its associ-
ation with BiP and that the degradative rate increased when
this association was terminated. This possibility was exam-
ined using anti-BiP antibodies to precipitate this protein, and
any polypeptide associated with it, from cell extracts treated
with NP-40, a nondenaturing detergent that preserves BiP-
containing complexes (Machamer et al., 1990). For these
experiments, the transfected cells were incubated with
[31S]methionine for 48 h to label BiP, which is a relatively
stable protein, and after a chase period of 4 h, incubated
again with [3'S]methionine for 10 min to label the newly
synthesized RI332 molecules. The amount of newly synthe-
sized R1332 polypeptides present in the cells was assessed in
a parallel sample by direct immunoprecipitation with anti-
ribophorin I antibodies under denaturing conditions. It was
found (Fig. 6, lane a) that no labeled truncated R1332 mole-
cules were recovered in the immunoprecipitates obtained
with anti-BiP antibodies under nondenaturing conditions
(Fig. 6, compare lane a with c), although large amounts of
BiP itself were precipitated. Thus, solubilization of the anti-
BiP immunoprecipitate with SDS followed by precipitation
with anti-ribophorin I did not yield either intact or truncated
ribophorin I (lane b). It can therefore be concluded that an
association with BiP is not responsible for the initial slower
rate of degradation of R1332 molecules.
It is noteworthy that in all the pulse-chase experiments that
were carried out (see Figs. 2 and 3) the apparent molecular
weight of R1332 remained constant throughout both phases
of degradation. Since we have shown that in BFA-treated
cells, the apparent molecular weight of the truncated ribo-
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Figure S. A truncated form ofribophorin I consisting ofa large por-
tion of the luminal domain is degraded with a biphasic kinetics.
Data from six independent experiments were used to calculate the
mean values for the two decay rates (k, = 0.012 f 0.002 min-';
k2 = 0.041 f 0.010 min-') and for the transition time between the
two phases (tTR = 49 t 6 min) . A biphasic decay curve for RI332
was plotted using these mean parameters. The shaded area indicates
one standard deviation of the rates and the error bar the standard
deviation of the transition time.Figure 6. Newly synthesized
R1332 does not associate with
BiP HeLa-Rí332 cells were
first labeled with [35S]methio-
nine for 48 h and, after achase
of 4 h labeled again with the
same precursor for an addi-
tional 10 min . Cell lysates
were prepared in a nondena-
turing buffer containing 1%
NP-40 and 0.05% SDS, and
two aliquots were used for im-
munoprecipitation with anti
BiP antibodies. The immunoprecipitates were eluted from the pro-
tein A-Sepharose beads with SDS and one sample (a) was directly
loaded onto the gel, whereas the second (b) was submitted to a sec-
ond cycle of immunoprecipitation using anti-ribophorin I (lane b),
as described in Materials and Methods. A third aliquot ofthe lysate
(c) was denatured in SDS and immunoprecipitated with anti-ribo-
phorin I under standard conditions (see Materials and Methods) .
Samples were analyzed on an 8% SDS-polyacrylamide gel and the
fluorograph was exposed for 4 d . The BiP recovered in lane b, in
which the second immunoprecipitation was carried out with anti-
ribophorin I antibodies, is probably brought down by renatured
anti-BiP antibody present in the immunoprecipitate recovered in
the first cycle of immunoprecipitation .
phorin increases as a result ofits O-glycosylation by Golgi en-
zymes relocated to the ER, itmay be concluded that transfer
of R1332 molecules from the ER to the second compartment
does not involve their passage through the Golgi apparatus .'
Since R1332 exhibits both phases of intracellular degrada-
tion, transformants expressing this protein were used to fur-
ther characterize the degradative processes .
Inhibitors ofLysosomal Function
orAutophagy Do Not Prevent the Degradation of
Truncated Ribophorins
Direct evidence that lysosomal enzymes are not involved in
the rapid turnover of Rí332 was obtained by examining the
effect on this process of agents that inhibit lysosomal func-
tion (Seglen, 1983), such as the lysosomotrophic drugs am-
monium chloride and chloroquine, and various lysosomal
protease inhibitors (Fig . 7) . None ofthese agents, nor other
drugs, such as colchicine and methyladenine, which inhibit
autophagy, or cycloheximide (Seglen, 1983), which inhibits
lysosomal function by an unknown mechanism, affected the
turnover of Rí332, as indicated by the amount of radioactive
protein remaining in the cell after a 90-min chase period in
the presence or the absence of each agent . In this respect,
the degradation of the truncated ribophorin resembles that
ofthea chain ofthe T cell antigen receptor complex, which
takes place intheER and is not inhibited by agents thatblock
lysosomal function (Lippincott-Schwartz et al ., 1988) .
Calcium Ionophores Completely Prevent the
Degradation ofRI332 , whileMonensinandCCCP
Prevent the Occurrence oftheSecondPhase, Probably
by Blocking Transport ofthe Truncated Ribophorin
to theSecond Degradative Site
The effect of a variety of cation-specific ionophores on the
degradation of Rí332 was first examined by measuring the
fraction of R1332 that remained after a 90-min chase period
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Figure 7 . Degradation of Rí332 does not occur in lysosomes. HeLa-
R1332 cultures were preincubated for 2 h with the drugs indicated,
except for cycloheximide, the cation-specific ionophores, and 1,10-
phenanthroline, which were added at the time of the chase. The
final concentration of each drug is indicated above the respective
bar. Cells were pulse-labeled for 5 min with [ 35S]methionine and
chased for 90 min in the presence ofthe inhibitors . Immunoprecipi-
tates obtained from cell lysates were analyzed by SDS-PAGE fol-
lowed by fluorography. The decrease in the normalized intensities
of the bands corresponding to Rí332 were compared with that ob-
tained from an untreated culture and percentages of inhibition were
calculated .
in the presence of each agent (Fig . 7) . The calcium iono-
phores A23187 and ionomycin almost completely blocked
the turnover of R1332, suggesting that appropriate concentra-
tions of intracellular calcium are required for the degrada-
tion . CCCP, aproton ionophore that inhibits oxidative phos-
phorylation (Heytler, 1963), and monensin, a carboxylic
ionophore that preferentially facilitates the transport of Na+
over K+ across membranes (Pressman and Fahim, 1982),
also markedly reduced the degradation of the anchorless
ribophorin in the 90-min chase period examined, but to a
significantly lesser extent than the calcium ionophores.
Since monensin and CCCP are known to inhibit vesicular
transport between membranous organelles (Tartakoff et al.,
1977; Tartakoff, 1983a,b), it was conceivable that they ex-
erted their effect by blocking transport of Rí332 from the ER
to the site where the second phase of degradation takes
place. Indeed, kinetic studies showed that in the presence of
monensin (Fig . 8 A) or CCCP (Fig. 8 B) the degradation of
R1332 was monophasic, proceeding to completion with half-
lives similar to that of the first degradative phase observed
in untreated cells . The prolongation of the firstphase in cells
treated with the ionophores establishes that it does not sim-
ply represent a lag period before true degradation begins .
To determine if these ionophores acted by preventing the
transition from one phase to another,CCCP was added after
60 min of chase, a time when the second degradative phase
had already begun . We found that in this case, (Fig . 8 B)
CCCP had no effect on the degradation, which proceeded to
completion at the same rate as in untreated cells . This indi-
cates that the ionophore does not slow down the second
phase of degradation, but rather, prevents the transition be-ó
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Figure 8. Pharmacological analysis of the degradation of R1332:
Complete inhibition by Call ionophores, prevention of the occur-
rence of the second phase ofdegradation by monensin and CCCP,
and monophasicdegradation at an intermediate rate inthe presence
of BFA. HeLa-RI332 cells were pulse labeled for 5 min with [35S]-
methionine and chased for up to 2 h in the absence (9) or in the
presence of various drugs affecting the turnover of81332. The Ca2+
ionophore A23187 (5 AM; o) was added together with the chase
medium, while cells treated with monensin (10 1,M; m) or BFA
(5 Ag/ml; o) were, in addition, preincubated with these drugs for
2 h or 30 min, respectively. (B) CCCP was either added together
with the chase medium (A) or after60 min of chase (o). The con-
trol (e) in this experiment, done in parallel with the CCCP-treated
samples shows somewhat slower decay ratesthan average. Samples
obtained at different chase periods were processed for immunopre-
cipitation, SDS-PAGE, and fluorography, and the data analyzed as
described in Materials and Methods.
tween the two phases, as expected if it blocked transfer of
81332 between two degradative sites. A similar experiment
cannot be carried out with monensin since there is a
significant delay after its addition before this drug exerts its
physiological effects on the cells.
In contrast to the effect of CCCP, the calcium ionophore
A23187 completely blocked the degradation process when
it was added at the beginning ofthe chase period (Fig. 8 A),
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Figure 9. Degradation of R1332 is blocked in cells incubated at 15
or 20°C. HeLa-R1332 cellswere pulse labeled with 135S]methionine
for 5 min and chased at 37°C (9), 20°C (o), or 15°C (o) for up
to 10.5 h. Immunoprecipitates obtained from cell lysates were ana-
lyzed by SDS-PAGE followed by fluorography. The degradation
rates were determined as described in Materials and Methods.
or after the second phase of degradation had begun (results
not shown). This inhibitory effect of A23187 was also ob-
served when it was added to the medium together with
EGTA (not shown), indicating that the ionophore acted by
depleting Call pools within the degradative compartments.
Other ionophores specific for potassium ions, such as the
neutral valinomycin and the carboxylic nigericin (Pressman
and Fahim, 1982), had no significant effect on the degrada-
tion of 81332 (Fig. 7).
Further support for the notion that the first phase ofdegra-
dation takes place in the ER, whereas the second takes place
in a physically distinct compartment to which the molecules
are transported by vesicular flow, was provided by experi-
ments in which the cells were treated with BFA, a drug
which leads to the back flow of Golgi constituents into the
ER (Lippincott-Schwartz et al., 1989; Doms et al., 1989;
Ulmer and Palade, 1989). In this case, the turnover of 81332
also became monóphasic (Fig. 8 A) but degradation pro-
ceeded at a rate intermediate between those ofthe two phases
observed in control cells (tin = 34 min). This suggests that
BFA leads to the intermixing of components of the second
site of degradation with those of the ER.
Degradation ofRI,u2DoesNotTake Place
at15or20'C
Since it has been previously shown that vesicular transport
from the ER to Golgi cisternae proceeds in cells incubated
at 20'C but is halted when the temperature is reduced to
15*C (Saraste and Kuismanen, 1984; Saraste et al., 1986;
Tartakoff, 1986; Tooze et al., 1988), we examined the effect
of incubation at these low temperatures on the kinetics of
degradation of 81332- We found, however, that at both tem-
peratures turnover of the truncated ribophorin was almost
completely suppressed (Fig. 9). Although the role ofvesicu-
lar flow between the two putative sites ofdegradation could
not be assessed from these experiments, the pronounced
temperature effect (t,q = 14 h at 20"C and tv2 = 32 h at
15'C) on the degradation rate suggests that this process in-
volves membrane-bound enzyme(s) whose activity depends
markedly on the fluidstateofthe lipidbilayer (De Pierre and
Dallner, 1975 ; Mitropoulos et al., 1980) and does not take
place wholly in a homogeneous soluble phase (Burdette and
Quinn, 1986).1,10-Phenanthroline, an InhibitorofMetalloproteases,
Prevents Degradation ofRI332
The turnover of 81332 was prevented when 2 mM 1,10-
phenanthroline, a chelator of divalent cations (such as Zn2+
and Fee+), which inhibits metalloproteases (Chlebowski
and Coleman, 1976), was added to the cells immediately af-
ter the pulse (Fig. 10B) . Degradation was also haltedwhen
the inhibitor was added after 45 min of chase (Fig . 10 C) .
Similar results (not shown) were obtained when the cells
were incubated with 3mM of the dipeptide cbz-glycylphenyl-
alanylamide, another metalloprotease inhibitor (Chlebowski
and Coleman, 1976) . These findings indicate that metallo-
proteases are involved in both degradative phases ofthe trun-
cated ribophorin .
Discussion
The experimentsjust presented show that, in contrast to the
intact ribophorin I, which is a highly stable protein (t  2 =
25 h) (Rosenfeld et al ., 1984), two truncated ribophorin I
polypeptides, one that is still membrane anchored but lacks
the last 116 amino acids of the cytoplasmic domain and an-
other that is released into the lumen ofthe ER and contains
only the amino terminal 332 residues, are rapidly degraded
soon after their synthesis without transfer to lysosomes . The
degradation of these polypeptides began within 10 min of
their synthesis and was unaffected by lysosomotropic agents
and inhibitors of lysosomal proteases. Other authors have
reported a similar nonlysosomal rapid degradation for unas-
sembled polypeptide subunits of proteins that are normally
transported to the cell surface. These include components of
the T cell (Lippincott-Schwartz et al ., 1988 ; Chen et al .,
1988 ; Bonifacino et al., 1989 ; Wileman et al., 1990a), ace-
tylcholine (Merlie et al ., 1982) and asialoglycoprotein
(Amara et al., 1989) receptors, and immunoglobulin chains
(Sitia et al ., 1990) . In addition, various mutant polypeptides,
such as a truncated variant of the a-subunit of ß-hexosamin-
idase found in cultured fibroblasts from certain Tay-Sachs
patients (Lau and Neufeld, 1989), a truncated influenza
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Figure 10. Both phases of degradation of 81332 involve the
function ofmetalloproteases . After pulse labeling for 5 min
with [35S]methionine, HeLa-R1332 cell cultures were in-
cubated under chase conditions for up to 3 h with no addi-
tions (A), with 1,10-phenanthroline (2 mM) added im-
mediately afterthe pulse (B), or after 45 min ofchase (C) .
Immunoprecipitation and data analysis were carried out as
described in Materials and Methods .
hemagglutinin molecule (Doyle et al ., 1986), and an a globin
chain that was introduced into the ER by an attached cleav-
able signal sequence (Stoller and Shields, 1989) were de-
graded by this process. In contrast to these cases, however,
the completely translocated ribophorin I variant (RI332) ap-
peared to be degraded in two distinct pre-Golgi compart-
ments, one which is the ER itself, or a portion of it, and a
second to which the protein was transferred by vesicular
flow. Thus, the degradation rate of 81332 was initially simi-
lar to that of the membrane-anchored variant (RI,6,), but af-
ter -50 min it increased more than threefold, and this in-
crease was prevented by treatment with monensin or CCCP,
ionophores which block protein transport from the ER to the
Golgi apparatus (Tärtakoff, 1983a,b ; Argon et al ., 1989) .
Moreover, CCCP did not affect the second phase ofdegrada-
tion when added after that phase had already begun .
Our finding that both monensin and CCCP prevented the
occurrence of the second phase of degradation of 81 332, but
did not reduce the first degradative rate, supports the notion
that the initial phase ofdegradation takes place in the ER it-
self. This is consistent with other previous observations
(Lippincott-Schwartz et al ., 1988) that this ionophore, when
applied at physiological pH, as done in our experiments, did
not affect the monophasic rate of degradation observed for
unassembled TCR subunits . The ionophores, therefore, are
likely to act by preventing the flow of RI332 to a second
compartment, rather than by preventing an enhanced degra-
dation in the ER because they change the ionic conditions
within this organelle . In this regard, it is worth noting that
Lippincott-Schwartz et al . (1988) observed that the rapid
nonlysosomal degradation of the TCRa chain began after a
20-min lag, which they interpreted as possibly reflecting the
time required for the transfer of the newly synthesized pro-
tein to a degradative compartment. In that system, however,
the ionophores apparently had little effect on the non-
lysosomal degradation and it was concluded that vesicular
movement was not involved in the transport . It is clear that
in our case there was no extended lag before degradation be-
gan since 37% of the R1332 molecules were degraded with
first order kinetics during the first 45-50 min .
64The degradation of both truncated ribophorin I variants
was prevented when the cellswere incubated at 20°C, a tem-
perature that allows exit ofproteins from the ER to the Golgi
apparatus (Saraste and Kuismanen, 1984) and, therefore, is
also likely to permit flow of the truncated molecules from
the first to the second degradative compartment if the latter
is on the natural route from the ER to the Golgi apparatus.
If this is the case, the stability of the truncated ribophorins
at 20°C would indicate that the proteolytic processes that
take place in the twopre-Golgi compartments are themselves
extremely sensitive to temperature, which would be ex-
pected if the degradation is carried out by membrane-bound
enzymes whose activity is affected by the fluidity of the
membrane lipids (DePierre and Dallner, 1975; Mitropoulos
et al., 1980). A similar inhibitory effect of low temperature
on pre-Golgi degradation has been reported for other pro-
teins (Chen et al. 1988; Stoller and Shields, 1989) .
The finding that Cal+ ionophores, in contrast to the pro-
ton/monovalent cation ionophores, almost completely blocked
degradation ofboth truncated ribophorins is ofconsiderable
interest. The effect of the Cat+ ionophores appears to be
caused by the depletion of the ER calcium pool since it oc-
curred even when EGTA was added to the medium. The
Cal+ concentration in the ER lumen has been estimated to
be several orders of magnitude higher than in the cytoplasm
(up to 3 mM, for review see Sambrook, 1990), and it has
been postulated that the major luminal resident proteins of
the ER, which have thecapacity to bind large amounts ofcal-
cium, form a gel within the ER lumen that prevents theirexit
towards the Golgi apparatus (Booth and Koch, 1989; Sam-
brook, 1990). In some cell types, Cat+ depletion induces
the secretion of luminal ER resident proteins and this is
thought to result either directly from the dissolution of the
gel (Booth and Koch, 1989)or from an ensuing mass vesicu-
lation of the ER membrane (Sambrook, 1990). It is, how-
ever, unlikely that the calcium ionophores prevented the
degradation of the truncated ribophorins by inducing their
exit from the degradative compartment(s) towards the Golgi
apparatus, since our studies were carried out with HeLa cell
transformants, and HeLa cells do not manifest the calcium
ionophore-induced secretion of ER resident proteins (Booth
and Koch, 1989) . Moreover, in the presence of the Cat+
ionophores, the truncated ribophorins were not secreted nor
did they undergo posttranslational modifications by Golgi
enzymes, which are observed when the cellsare treated with
BFA.2 The most likely explanations for the effect of the
Cat+ ionophores are that, either the proteolytic enzymes
that carry out the pre-Golgi degradation of R1332 require
high levels of Cat+ for their function, or Cat+ depletion, by
altering the conformation of the truncated ribophorin
renders it resistant to the action of the proteases. The inhibi-
tory effect of the Cat+ ionophores that we observed is in
marked contrast with the behavior of the unassembled a
chain ofthe TCR in T cell hybridomas, which in the presence
of a Cal+ ionophore was found to be degraded by the non-
lysosomal pathway (Lippincott-Schwartz et al., 1988), and
with the behavior of TCR-ß and CD3-Schains in transfected
cells, whose degradation was accelerated by the ionophore
after a 1-h lag period (Wileman et al., 1991). We must con-
clude that, if the same enzymes are involved in the degrada-
tion of all these proteins, the differential effect of Cat+ must
reflect a differential effect ofthis ion on the conformation of
the various proteins.
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One of our most striking findings is that both phases of
degradation of RI332 were completely inhibited by 1,10-
phenanthroline, a metal chelator that inhibits Zn2+-depen-
dent metalloproteases (Chlebowski and Coleman, 1976).
This strongly indicates that a metalloprotease, or a family of
such enzymes, carries out the pre-Golgi degradative pro-
cesses. Although the presence of a Zn2+-dependent endo-
peptidase activity has been demonstrated in microsomes
from several animal species (Mumford et al., 1980), the in-
volvement of such an activity in protein degradation within
the ER has not been reported previously.
The interpretation that the biphasic degradation of RI332,
indeed, reflects the participation of two distinct subcellular
compartments is consistent with the effect of the macrolid
antibiotic BFA. In cells treated with this drug, the degrada-
tion became monophasic and occurred with a rate intermedi-
ate between those of the two phases observed in the control
cells. BFA is known to induce disassembly of the Golgi ap-
paratus and a relocation of Golgi enzymes to the ER
(Fujiwara et al ., 1988; Lippincott-Schwartz et al ., 1989;
Doms et al ., 1989 ; Ulmer and Palade, 1989). This relocation
is thought to occur through an "intermediate or a "salvage
compartment" (see Pelham, 1989)that is normally traversed
by proteins "en route" to the Golgi apparatus (Lippincott-
Schwartz et al., 1990). Ifthe second compartment of degra-
dation of RI332 corresponds to the intermediate compart-
ment, or is en route to it, it would be expected that BFA leads
to an equilibration of the environment within that compart-
ment with that of the ER itself.
Several inferences can be made from the behavior of the
truncated ribophorins with respect to the features of the in-
tact proteins that are responsible for their retention in that
organelle or determine their turnover rates. The segregation
within the ER of some transmembrane proteins, such as the
adenovirus E19 glycoprotein (Pääbo et al., 1987), several
forms of UDP-glucuronyl transferase (Nilsson et al., 1989;
Jackson et al ., 1990), and possible 3-hydroxy-3-methylglu-
taryl coenzyme A reductase (Jackson et al., 1990), appears
to be due to the presence within the extreme carboxy-terminal
segments ofthe polypeptides, which are exposed on the cyto-
plasmic side ofthe ER membrane. Such signals would deter-
mine either the retention of the proteins in the ER or the
retrieval of "escaped" molecules from a post-ER "salvage"
compartment. These carboxy-terminal signals show signifi-
cant sequence variation but contain two essential lysine resi-
dues, one in the third position from the COOH terminus, and
the other in the fourth or fifth position (Jackson et al., 1990) .
On the other hand, ribophorins I and H and a subunit of the
signal peptidase (SPC22/23) (Shelness et al., 1988) do not
contain retention signals of this type at theirCOON termini .
In fact, when added to reporter proteins that are normally
transferred to the plasma membrane, the COOH-terminal
segments of ribophorins do not lead to ER retention in the
chimeric protein (Jackson et al., 1990) . Although our ex-
periments with the truncated ribophorin I molecules, one
which lacks the extreme COOH-terminal segment and an-
other which is not even membrane anchored, would be con-
sistent with the notion that a signal that prevents the egress
of ribophorin I from the ER is located in its luminal domain,
it is quite possible that the truncated proteins are retained in
the ER simply because they are misfolded and, therefore, are
recognizedby a system that effects quality control on newly
synthesized polypeptides . The behavior of the truncated
65ribophprins would then resemble that of truncated forms of
viral envelope glycoproteins that are also retained in the ER
(see Rose and Doms, 1988) . It is noteworthy, however, that
R1332 molecules were not associated with BiP, a protein that
contributes to the retention of some misfoldedproteins in the
ER, and, therefore, their retention must involve some other
mechanism.
Native ribophorinI is part of a protein network within the
ER membrane that includes ribophorin11, in a 1:1 stoichio-
metric ratio with ribophorin I, and components of the trans-
location apparatus, such as the ribosome binding sites and
the signal recognition particle receptor (Kreibich et al.,
1978a,b; Marcantonio et al., 1984 ; Amar-Costesec et al.,
1984; Yu et al., 1989). The normal retention of ribophorin
I in the ER may, therefore, be a consequence of its incorpora-
tion into this network, which would prevent its entrance into
the bulk flow carrier vesicles that exit from the ER (Wieland
et al ., 1987). If this is the case, the same sequences that me-
diate theincorporation ofthis protein intothe network would,
in effect, be serving as retention signals. Moreover, the sta-
bility ofthe native ribophorin would result from its incorpo-
ration into the network, which sequesters it from the degra-
dative machinery, so that the truncated variants would be
unstable simply because they lack the capacity to associate
with the network. This would imply that, normally, assem-
bled ribophorin molecules contain features that could be rec-
ognized by the degradative system but are not accessible to
this system whenthe proteins are part of thenetwork. Similar
alternative explanations have been proposed (Bonifacino et
al., 1990; Wileman et al ., 1990b) to explain the instability
of unassembled subunits of the TCR complex. For the ci and
A subunits ofthis complex (Bonifacino et al ., 1990; Wileman
et al., 1990b), as well as for unassembled transmembrane
immunoglobulin heavy chains (Williams et al ., 1990), how-
ever, it has been shown that the signals that lead to rapid deg-
radation of these polypeptides are contained in their trans-
membrane domains and that, in the case of the «-subunit of
the TCR, such signals are masked during multimerization,
since the same domain directly mediates the association with
other subunits (Manolios et al ., 1990). In contrast to the ex-
amples just mentioned, our results with RI332 clearly show
that a membrane anchor is not essential for rapid pre-Golgi
degradation. A similar conclusion can be drawn from pre-
vious observations on the rapid turnover of other abnormal
luminal protein molecules, such as a globin (Stoller and
Shields, 1988) and mutant a,-antitrypsin polypeptides (Le
et al., 1990) .
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